Omnicell (NASDAQ: OMCL) reported Q2 EPS of $0.28, $0.04 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $112.8 million versus the consensus estimate of $121.35 million.

"Omnicell's business has grown well from 2014 with a strong contribution from new customer orders. A small sequential decline in revenue due to timing of customer implementations affected our results for the second quarter, but our order intake and the pipeline of new sales opportunities demonstrate that we have not lost market momentum." said Randall Lipps, Omnicell president, chairman and CEO. "Driven by our three-leg growth strategy of differentiated products, expansion into new markets and targeted acquisitions, the company has all the ingredients for continued success."

For earnings history and earnings-related data on Omnicell (OMCL) click here.